Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Tobert JA, Bell GD, Birtwell J, James I, Kukovetz WR, Pryor JS, Buntinx A, Holmes IB, Chao YS, Bolognese JA.

J Clin Invest. 1982 Apr;69(4):913-9.

PMID:
6918402
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.

Mabuchi H, Haba T, Tatami R, Miyamoto S, Sakai Y, Wakasugi T, Watanabe A, Koizumi J, Takeda R.

N Engl J Med. 1981 Aug 27;305(9):478-82.

PMID:
7254297
[PubMed - indexed for MEDLINE]
3.

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

Tobert JA.

Circulation. 1987 Sep;76(3):534-8.

PMID:
3113763
[PubMed - indexed for MEDLINE]
4.

Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.

Davignon J, Hanefeld M, Nakaya N, Hunninghake DB, Insull W Jr, Ose L.

Am J Cardiol. 1998 Aug 27;82(4B):32J-39J.

PMID:
9737644
[PubMed - indexed for MEDLINE]
5.

Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.

Tobert JA, Hitzenberger G, Kukovetz WR, Holmes IB, Jones KH.

Atherosclerosis. 1982 Jan;41(1):61-5.

PMID:
6918220
[PubMed - indexed for MEDLINE]
6.

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

Grundy SM, Vega GL.

J Lipid Res. 1985 Dec;26(12):1464-75.

PMID:
3853581
[PubMed - indexed for MEDLINE]
Free Article
7.

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

Illingworth DR, Sexton GJ.

J Clin Invest. 1984 Dec;74(6):1972-8.

PMID:
6569064
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

Davidson M, McKenney J, Stein E, Schrott H, Bakker-Arkema R, Fayyad R, Black D.

Am J Cardiol. 1997 Jun 1;79(11):1475-81.

PMID:
9185636
[PubMed - indexed for MEDLINE]
9.

Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.

Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.

Am J Cardiol. 1995 Jul 13;76(2):129A-135A.

PMID:
7604788
[PubMed - indexed for MEDLINE]
10.
11.
12.
13.

Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.

Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.

Eur J Clin Nutr. 1994 Dec;48(12):859-65.

PMID:
7889894
[PubMed - indexed for MEDLINE]
14.

Regulation of cholesterol synthesis and binding of lipoproteins in cultured rat intestinal epithelial cells.

Nano JL, Barbaras R, NĂ©grel R, Rampal P.

Biochim Biophys Acta. 1986 Mar 21;876(1):72-9.

PMID:
3633199
[PubMed - indexed for MEDLINE]
15.

Physiologic mechanisms of action of lovastatin in nephrotic syndrome.

Aguilar-Salinas CA, Barrett PH, Kelber J, Delmez J, Schonfeld G.

J Lipid Res. 1995 Jan;36(1):188-99.

PMID:
7706943
[PubMed - indexed for MEDLINE]
Free Article
16.

Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.

Insull W Jr, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ.

Arch Intern Med. 1994 Nov 14;154(21):2449-55.

PMID:
7979841
[PubMed - indexed for MEDLINE]
17.

Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Plosker GL, McTavish D.

Drugs. 1995 Aug;50(2):334-63. Review.

PMID:
8521762
[PubMed - indexed for MEDLINE]
18.

Lovastatin: a new cholesterol-lowering agent.

McKenney JM.

Clin Pharm. 1988 Jan;7(1):21-36. Review.

PMID:
3278832
[PubMed - indexed for MEDLINE]
19.

A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.

Hanes DS, Nicholson PG, Raval DD, Hooper FL, Behrens MT, Weir MR.

Am J Ther. 1997 Feb-Mar;4(2-3):85-91.

PMID:
10423597
[PubMed - indexed for MEDLINE]
20.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk